Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3319 | 2010 | 36.2 | 73% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
316 | 3 | RHEUMATOLOGY//RHEUMATOID ARTHRITIS//RHEUMATOL | 39766 |
1684 | 2 | METHOTREXATE//FOLATE RECEPTOR//REDUCED FOLATE CARRIER | 6769 |
3319 | 1 | METHOTREXATE//RHEUMATOID ARTHRITIS//METHOTREXATE POLYGLUTAMATES | 2010 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | METHOTREXATE | authKW | 1326212 | 34% | 13% | 681 |
2 | RHEUMATOID ARTHRITIS | authKW | 261324 | 29% | 3% | 584 |
3 | METHOTREXATE POLYGLUTAMATES | authKW | 168830 | 1% | 65% | 17 |
4 | RHEUMATOLOGY | WoSSC | 163061 | 52% | 1% | 1036 |
5 | JOURNAL OF RHEUMATOLOGY | journal | 76439 | 13% | 2% | 253 |
6 | SUBCUTANEOUS METHOTREXATE | authKW | 63290 | 0% | 83% | 5 |
7 | DMARDS | authKW | 52829 | 2% | 10% | 34 |
8 | DISEASE MODIFYING ANTIRHEUMATIC DRUGS | authKW | 51154 | 2% | 10% | 33 |
9 | MX 68 | authKW | 47465 | 0% | 63% | 5 |
10 | CH 1504 | authKW | 45570 | 0% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Rheumatology | 163061 | 52% | 1% | 1036 |
2 | Dermatology | 3302 | 10% | 0% | 204 |
3 | Pharmacology & Pharmacy | 888 | 15% | 0% | 292 |
4 | Medicine, General & Internal | 863 | 11% | 0% | 222 |
5 | Immunology | 55 | 4% | 0% | 90 |
6 | Toxicology | 33 | 2% | 0% | 41 |
7 | Allergy | 10 | 1% | 0% | 11 |
8 | Geriatrics & Gerontology | 9 | 1% | 0% | 13 |
9 | Medicine, Research & Experimental | 5 | 2% | 0% | 38 |
10 | Respiratory System | 5 | 1% | 0% | 21 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | RHEUMATOL | 29278 | 14% | 1% | 279 |
2 | ADV TRAINING HLTH SCI TECHNOL | 27118 | 0% | 36% | 5 |
3 | MOL ONCOL GRP CI | 22776 | 0% | 25% | 6 |
4 | CLIN PHARMSHINAGAWA KU | 20252 | 0% | 67% | 2 |
5 | HIGHER HLTH SCI NORTH ISCS N | 20252 | 0% | 67% | 2 |
6 | ABORAT INT DRUG MONITORING | 15190 | 0% | 100% | 1 |
7 | ABT INNERE MED HAMATOL 5 | 15190 | 0% | 100% | 1 |
8 | ALLERG SKIN DIS | 15190 | 0% | 100% | 1 |
9 | ALLGEMEINE KLIN POLIKLIN KINDERHEILKUNDE | 15190 | 0% | 100% | 1 |
10 | ANESTEZIYOL REANIMAYSON ANABILIM DALI | 15190 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF RHEUMATOLOGY | 76439 | 13% | 2% | 253 |
2 | BRITISH JOURNAL OF RHEUMATOLOGY | 34574 | 4% | 3% | 71 |
3 | ARTHRITIS AND RHEUMATISM | 26492 | 7% | 1% | 134 |
4 | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 26473 | 5% | 2% | 98 |
5 | SEMINARS IN ARTHRITIS AND RHEUMATISM | 12360 | 2% | 2% | 40 |
6 | ZEITSCHRIFT FUR RHEUMATOLOGIE | 11428 | 2% | 2% | 42 |
7 | ANNALS OF THE RHEUMATIC DISEASES | 9783 | 4% | 1% | 76 |
8 | CLINICAL RHEUMATOLOGY | 8238 | 3% | 1% | 54 |
9 | RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 5837 | 1% | 2% | 24 |
10 | AKTUELLE RHEUMATOLOGIE | 5612 | 1% | 2% | 21 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | METHOTREXATE | 1326212 | 34% | 13% | 681 | Search METHOTREXATE | Search METHOTREXATE |
2 | RHEUMATOID ARTHRITIS | 261324 | 29% | 3% | 584 | Search RHEUMATOID+ARTHRITIS | Search RHEUMATOID+ARTHRITIS |
3 | METHOTREXATE POLYGLUTAMATES | 168830 | 1% | 65% | 17 | Search METHOTREXATE+POLYGLUTAMATES | Search METHOTREXATE+POLYGLUTAMATES |
4 | SUBCUTANEOUS METHOTREXATE | 63290 | 0% | 83% | 5 | Search SUBCUTANEOUS+METHOTREXATE | Search SUBCUTANEOUS+METHOTREXATE |
5 | DMARDS | 52829 | 2% | 10% | 34 | Search DMARDS | Search DMARDS |
6 | DISEASE MODIFYING ANTIRHEUMATIC DRUGS | 51154 | 2% | 10% | 33 | Search DISEASE+MODIFYING+ANTIRHEUMATIC+DRUGS | Search DISEASE+MODIFYING+ANTIRHEUMATIC+DRUGS |
7 | MX 68 | 47465 | 0% | 63% | 5 | Search MX+68 | Search MX+68 |
8 | CH 1504 | 45570 | 0% | 100% | 3 | Search CH+1504 | Search CH+1504 |
9 | THERAPEUTIC SEGMENT | 45570 | 0% | 100% | 3 | Search THERAPEUTIC+SEGMENT | Search THERAPEUTIC+SEGMENT |
10 | LONGTERM TREATMENT | 34716 | 0% | 57% | 4 | Search LONGTERM+TREATMENT | Search LONGTERM+TREATMENT |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | RAU, R , HERBORN, G , (2004) BENEFIT AND RISK OF METHOTREXATE TREATMENT IN RHEUMATOID ARTHRITIS.CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. VOL. 22. ISSUE 5. P. S83-S94 | 124 | 75% | 29 |
2 | BANNWARTH, B , LABAT, L , MORIDE, Y , SCHAEVERBEKE, T , (1994) METHOTREXATE IN RHEUMATOID-ARTHRITIS - AN UPDATE.DRUGS. VOL. 47. ISSUE 1. P. 25-50 | 119 | 87% | 122 |
3 | ROMAO, VC , LIMA, A , BERNARDES, M , CANHAO, H , FONSECA, JE , (2014) THREE DECADES OF LOW-DOSE METHOTREXATE IN RHEUMATOID ARTHRITIS: CAN WE PREDICT TOXICITY?.IMMUNOLOGIC RESEARCH. VOL. 60. ISSUE 2-3. P. 289 -310 | 98 | 63% | 4 |
4 | RAU, R , (1994) METHOTREXATE TREATMENT OF RHEUMATOID-ARTHRITIS 1994 - AN OVERVIEW.ZEITSCHRIFT FUR RHEUMATOLOGIE. VOL. 53. ISSUE 4. P. 199-229 | 125 | 84% | 12 |
5 | VERDIER, MC , TRIBUT, O , BODEAU, S , RIHOUEY, D , BENTUE-FERRER, D , (2011) LEVEL OF EVIDENCE FOR THERAPEUTIC DRUG MONITORING OF LOW DOSE METHOTREXATE IN INFLAMMATORY DISEASES.THERAPIE. VOL. 66. ISSUE 1. P. 63 -72 | 71 | 88% | 1 |
6 | CRONSTEIN, BN , (2005) LOW-DOSE METHOTREXATE: A MAINSTAY IN THE TREATMENT OF RHEUMATOID ARTHRITIS.PHARMACOLOGICAL REVIEWS. VOL. 57. ISSUE 2. P. 163-172 | 81 | 64% | 240 |
7 | WEST, SG , (1997) METHOTREXATE HEPATOTOXICITY.RHEUMATIC DISEASE CLINICS OF NORTH AMERICA. VOL. 23. ISSUE 4. P. 883-& | 99 | 84% | 59 |
8 | CHEN, YH , ZOU, K , SUN, JH , YANG, Y , LIU, G , (2017) ARE GENE POLYMORPHISMS RELATED TO TREATMENT OUTCOMES OF METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS? A SYSTEMATIC REVIEW AND META-ANALYSIS.PHARMACOGENOMICS. VOL. 18. ISSUE 2. P. 175 -195 | 66 | 80% | 0 |
9 | VISSER, K , VAN DER HEIJDE, DMFM , (2009) RISK AND MANAGEMENT OF LIVER TOXICITY DURING METHOTREXATE TREATMENT IN RHEUMATOID AND PSORIATIC ARTHRITIS: A SYSTEMATIC REVIEW OF THE LITERATURE.CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. VOL. 27. ISSUE 6. P. 1017-1025 | 59 | 87% | 41 |
10 | COLEBATCH, AN , MARKS, JL , EDWARDS, CJ , (2011) SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, INCLUDING ASPIRIN AND PARACETAMOL (ACETAMINOPHEN) IN PEOPLE RECEIVING METHOTREXATE FOR INFLAMMATORY ARTHRITIS (RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS, PSORIATIC ARTHRITIS, OTHER SPONDYLOARTHRITIS).COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 11. P. - | 84 | 60% | 12 |
Classes with closest relation at Level 1 |